Diaceutics PLC is a publicly traded company listed on the Alternative Investment Market (AIM) of the London Stock Exchange under the ticker DXRX, meaning its ownership is distributed among institutional asset managers, public investors, and corporate insiders. Key significant equity holders include company co-founder and executive leader Peter Keeling, alongside institutional investment firms like Gresham House Asset Management and Canaccord Genuity Group, which maintain substantial ownership blocks in the precision medicine data analytics enterprise.